BCB Bancorp CCO reports 7,185-option grant at $9.91 on 02/24/25

Rhea-AI Filing Summary

BCB Bancorp, Inc. (BCBP) reported an insider equity award. The company’s Chief Compliance Officer filed a Form 4 disclosing a grant of options to purchase 7,185 shares at an exercise price of $9.91 on 02/24/2025.

The new option becomes exercisable on 02/24/2026 and expires on 02/24/2035, and vests 1/3 per year commencing on the first anniversary of the grant date. Following the transactions reported, the officer lists 1,380 shares of common stock beneficially owned (direct). The filing also lists previously awarded options outstanding, including 12,500 options (exercise price $12.40, expiring 09/13/2027) and 5,000 options (exercise price $10.55, expiring 12/26/2025).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sievewright Sandra

(Last) (First) (Middle)

104-110 AVENUE C

(Street)

BAYONNE NJ 07002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BCB BANCORP INC [ BCBP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								1,380	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase	$9.91	02/24/2025		A		7,185		02/24/2026(1)	02/24/2035	Common Stock	7,185	$0	7,185	D
Option to purchase	$12.4							09/13/2018	09/13/2027	Common stock	12,500		12,500	D
Option to purchase	$10.55							12/29/2016	12/26/2025	Common stock	5,000		5,000	D

Explanation of Responses:

1. Stock options vest at the rate of 1/3 per year commencing on the first anniversary of the grant date.

	/s/ Sandra Sievewright, by Edward Hogan, attorney-in-fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BCBP report on Form 4?

A grant of options to purchase 7,185 BCB Bancorp shares at an exercise price of $9.91 on 02/24/2025.

Who is the reporting person in the BCBP Form 4?

An officer of BCB Bancorp, listed as Chief Compliance Officer.

When do the newly granted BCBP options become exercisable and when do they expire?

They become exercisable on 02/24/2026 and expire on 02/24/2035.

What is the vesting schedule for the new BCBP option grant?

They vest at 1/3 per year starting on the first anniversary of the 02/24/2025 grant date.

How many BCBP common shares does the officer report owning after the transaction?

The filing lists 1,380 shares of common stock beneficially owned (direct).

What other BCBP options are outstanding for the officer?

Options for 12,500 shares at $12.40 expiring 09/13/2027, and 5,000 shares at $10.55 expiring 12/26/2025.